Wijnand Helfrich
- Molecular Biology top 5%
- Immunology top 2%
- Oncology top 2%
- Radiology, Nuclear Medicine and Imaging top 1%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Edwin BremerMarco de BruynDouwe F. SamploniusLou de LeijValerie R. WiersmaIgle J. de JongHildo J.K. AnaniasLou F. M. H. de Leij
- Topics
- Monoclonal and Polyclonal Antibodies Research (30 papers)Immunotherapy and Immune Responses (24 papers)CAR-T cell therapy research (24 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Wijnand Helfrich
112 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 1.7k
- Immunology 1.4k
- Oncology 1.2k
- Radiology, Nuclear Medicine and Imaging 998
- Pulmonary and Respiratory Medicine 389
Countries citing papers authored by Wijnand Helfrich
This map shows the geographic impact of Wijnand Helfrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wijnand Helfrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wijnand Helfrich more than expected).
Fields of papers citing papers by Wijnand Helfrich
This network shows the impact of papers produced by Wijnand Helfrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wijnand Helfrich. The network helps show where Wijnand Helfrich may publish in the future.
Co-authorship network of co-authors of Wijnand Helfrich
This figure shows the co-authorship network connecting the top 25 collaborators of Wijnand Helfrich. A scholar is included among the top collaborators of Wijnand Helfrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wijnand Helfrich. Wijnand Helfrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 8 | |
| 4 | 10 | |
| 5 | 29 | |
| 6 | 18 | |
| 7 | 56 | |
| 8 | 49 | |
| 9 | Targeting human prostate cancer xenografts with In-111-labeled D2B IgG, F(ab ')2 and Fab fragments in nude mice | 0 |
| 10 | 24 | |
| 11 | A Novel I-123-Cubane Labelled Bombesin for Imaging GRP Receptor-Expressing Prostate Cancer Cells | 1 |
| 12 | 32 | |
| 13 | 26 | |
| 14 | 69 | |
| 15 | 101 | |
| 16 | 40 | |
| 17 | 2 | |
| 18 | 27 | |
| 19 | 9 | |
| 20 | 1 |
About Wijnand Helfrich
Wijnand Helfrich is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 114 papers that have together received 3.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (30 papers), Immunotherapy and Immune Responses (24 papers) and CAR-T cell therapy research (24 papers). The work is most often cited by research in Immunology (1.4k citations), Oncology (1.2k citations) and Radiology, Nuclear Medicine and Imaging (998 citations). Wijnand Helfrich has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Edwin Bremer, Marco de Bruyn, Douwe F. Samplonius, Lou de Leij, Valerie R. Wiersma, Igle J. de Jong, Hildo J.K. Ananias, Lou F. M. H. de Leij, Bram ten Cate and Grietje Molema. Their work appears in journals such as Journal of Biological Chemistry, Blood and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.